Tenax Therapeutics (TENX) Revenue (2010 - 2015)

Tenax Therapeutics has disclosed Revenue across 5 years of filings, most recently posting $49286.0 for Q2 2015.

• In Q2 2015, Revenue changed N/A year-over-year to $49286.0; the TTM figure through Jun 2016 stood at $49286.0 (down 94.91% YoY), while the FY2015 annual figure was $49286.0, changed N/A from the prior year.
• Revenue came in at $49286.0 for Q2 2015 at Tenax Therapeutics, down from $181572.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $514872.0 in Q4 2012 to a low of $24873.0 in Q3 2011.
• Average Revenue over 4 years is $152266.0, with a median of $95487.0 recorded in 2012.
• Year-over-year, Revenue jumped 993.94% in 2012 and soared 50.0% in 2013.
• Over 4 years, Revenue stood at $95159.0 in 2011, then jumped by 441.06% to $514872.0 in 2012, then plunged by 64.73% to $181572.0 in 2013, then tumbled by 72.86% to $49286.0 in 2015.
• Per Business Quant data, the three most recent Revenue figures were $49286.0 in Q2 2015, $181572.0 in Q2 2013, and $222388.0 in Q1 2013.